Showing results (391-400 of 435) with videos related to

Sort By:
Pageof 44
Conservation Biology : the Journal of the Society for Conservation Biology|October 27, 2021
Predicting landscape-scale biodiversity recovery by natural tropical forest regrowthPablo V Prieto, Jacob J Bukoski, Felipe S M Barros, et al.
The American Journal of Psychiatry|June 4, 2002
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorderRobert M Bilder, Robert S Goldman, Jan Volavka, et al.
Neuroscience Letters|April 13, 2005
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophreniaDaniel J Müller, Tim A Klempan, Vincenzo De Luca, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2005
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophreniaDaniel J Müller, Vincenzo De Luca, Tricia Sicard, et al.
Trends in Ecology & Evolution|November 13, 2007
Mind the sustainability gapJoern Fischer, Adrian D Manning, Will Steffen, et al.
Journal of Virology|May 20, 2026
Tonic and early interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface culturesRinu Sivarajan, Paul C Kirchgatterer, Jan Lawrenz, et al.
Journal of Clinical Psychopharmacology|July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose studyBruce J Kinon, Jan Volavka, Virginia Stauffer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 25, 2011
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapyJoseph I Friedman, Jean-Pierre Lindenmayer, Frances Alcantara, et al.
Pageof 44